monkeybusinessimages/iStock via Getty Images AbCellera Biologics (ABCL) is up ~35% in Monday morning trading after announcing top-line phase 2 data for ABCL635, its candidate for moderate-to-severe vasomotor symptoms (hot flashes)…
Tag:
